| SOCS3 |
SOCS3, CIS3, SSI3: Suppressor of cytokine signaling 3 |
LATS1 |
LATS1, WARTS: Serine/threonine-protein kinase LATS1 |
22.940 |
Evidence |
|
| WASL |
WASL: Neural Wiskott-Aldrich syndrome protein |
MAP2K5 |
IPI00219607 |
22.940 |
Evidence |
|
| MAPKAPK3 |
MAPKAPK3: MAP kinase-activated protein kinase 3 |
MAPK14 |
MAPK14, CSBP, CSBP1, CSBP2, CSPB1, MXI2: Mitogen-activated protein kinase 14 |
22.890 |
Evidence |
|
| SH2D2A |
SH2D2A, SCAP, TSAD, VRAP: SH2 domain-containing protein 2A |
SLA |
SLA, SLAP, SLAP1: SRC-like-adapter |
22.890 |
Evidence |
|
| RPS6KA1 |
RPS6KA1, RSK1: Ribosomal protein S6 kinase alpha-1 |
BLNK |
BLNK, BASH, SLP65: B-cell linker protein |
22.890 |
Evidence |
|
| SPTAN1 |
IPI00413728 |
STAM |
STAM, STAM1: Signal transducing adapter molecule 1 |
22.890 |
Evidence |
|
| LCP2 |
LCP2: Lymphocyte cytosolic protein 2 |
MAP4K1 |
MAP4K1, HPK1: Mitogen-activated protein kinase kinase kinase kinase 1 |
22.890 |
Evidence |
O
|
| TRAF2 |
TRAF2, TRAP3: TNF receptor-associated factor 2 |
TRADD |
TRADD: Tumor necrosis factor receptor type 1-associated DEATH domain protein |
22.890 |
Evidence |
|
| TRAF2 |
TRAF2, TRAP3: TNF receptor-associated factor 2 |
TRAF1 |
TRAF1, EBI6: TNF receptor-associated factor 1 |
22.890 |
Evidence |
|
| STAT5B |
STAT5B: Signal transducer and activator of transcription 5B |
OSBPL11 |
OSBPL11, ORP11, OSBP12: Oxysterol-binding protein-related protein 11 |
22.890 |
Evidence |
|
| CRKL |
CRKL: Crk-like protein |
BLNK |
BLNK, BASH, SLP65: B-cell linker protein |
22.890 |
Evidence |
|
| CRKL |
CRKL: Crk-like protein |
VASP |
VASP: Vasodilator-stimulated phosphoprotein |
22.890 |
Evidence |
|
| SYK |
SYK: Tyrosine-protein kinase SYK |
SH3BP5 |
IPI00006776 |
22.890 |
Evidence |
|
| STAT5A |
STAT5A, STAT5: Signal transducer and activator of transcription 5A |
OSBPL11 |
OSBPL11, ORP11, OSBP12: Oxysterol-binding protein-related protein 11 |
22.890 |
Evidence |
|
| CSK |
CSK: Tyrosine-protein kinase CSK |
PASK |
PASK, KIAA0135: PAS domain-containing serine/threonine-protein kinase |
22.890 |
Evidence |
|
| BRCA1 |
BRCA1, RNF53: Breast cancer type 1 susceptibility protein |
BATF |
BATF: Basic leucine zipper transcriptional factor ATF-like |
22.890 |
Evidence |
|
| TYK2 |
TYK2: Non-receptor tyrosine-protein kinase TYK2 |
PASK |
PASK, KIAA0135: PAS domain-containing serine/threonine-protein kinase |
22.890 |
Evidence |
|
| VAV1 |
VAV1, VAV: Proto-oncogene vav |
IRS2 |
IRS2: Insulin receptor substrate 2 |
22.890 |
Evidence |
|
| VAV1 |
VAV1, VAV: Proto-oncogene vav |
SH2D2A |
SH2D2A, SCAP, TSAD, VRAP: SH2 domain-containing protein 2A |
22.890 |
Evidence |
|
| LAMC1 |
LAMC1, LAMB2: Laminin subunit gamma-1 precursor |
SERPINF1 |
SERPINF1, PEDF: Pigment epithelium-derived factor precursor |
22.890 |
Evidence |
|
| MYB |
MYB: Myb proto-oncogene protein |
HDAC1 |
HDAC1, RPD3L1: Histone deacetylase 1 |
22.890 |
Evidence |
|
| MET |
MET: Hepatocyte growth factor receptor precursor |
MST1R |
MST1R, PTK8, RON: Macrophage-stimulating protein receptor precursor |
22.890 |
Evidence |
|
| CTSG |
CTSG: Cathepsin G precursor |
CMA1 |
CMA1, CYH, CYM: Chymase precursor |
22.890 |
Evidence |
|
| CTSB |
CTSB, CPSB: Cathepsin B precursor |
CTSS |
CTSS: Cathepsin S precursor |
22.890 |
Evidence |
|
| SERPINA7 |
SERPINA7, TBG: Thyroxine-binding globulin precursor |
CFH |
CFH, HF, HF1, HF2: Complement factor H precursor |
22.890 |
Evidence |
|